EirGenix, Inc products

CRM197 (Cross Reacting Material 197) is a non-toxic mutant of diphtheria toxin (58 Kd). CRM197 has been tested in animals studies and it has been demonstrated to lack toxicity. CRM197 can be used as a carrier protein for vaccine delivery. It acts by helping polysaccharide antigens to bind on and be internalized into antigen-presenting cells. This in turn induces T-cell-dependent responses.

Product: EG74032 CRM197 Carrier Protein. Target: Carrier protein for conjugate vaccines. Status: GMP manufacturing.

Product: New Formulation. Indication: Cancer. Target: HER2. Status: Preclinical.

Product: EG62054 Biosimilar. Indication: Undisclosed. Target: Undisclosed. Status: Preclinical.